S&P 500
5,916.12
+2.0%
+$113.30
DJI
42,320.18
+1.7%
+$717.11
NASDAQ
19,169.03
+2.3%
+$431.82
Bitcoin
109,694.00
+0.6%
+668.68
AAPL
$200.33
+2.6%
+$5.06
AMZN
$205.48
+2.2%
+$4.49
GOOG
$174.03
+2.6%
+$4.44
META
$641.40
+2.3%
+$14.34
MSFT
$459.66
+2.1%
+$9.48
NVDA
$135.10
+2.9%
+$3.81
TSLA
$359.97
+6.1%
+$20.63
Anebulo Pharmaceuticals (NASDAQ: ANEB)
$1.09
(-2.7%)
-$0.03
Price as of May 22, 2025, 3:45 p.m. ET
Anebulo Pharmaceuticals Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Anebulo Pharmaceuticals Company Info
Anebulo Pharmaceuticals, Inc. engages in the provision of pharmaceutical services. The firm’s product candidate is ANEB-001, a potent, small molecule cannabinoid receptor antagonist, designed to address the unmet medical need for a specific antidote for cannabinoid overdose. The company was founded by Joseph F. Lawler on April 23, 2020 and is headquartered in Lakeway, TX.
News & Analysis
No articles found.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.